A biotech built for the hardest part of the journey.
We exist because scientific promise still fails to reach patients in rare and ultra-rare disease. Our work is to change the structural reasons why.
Who we are
Pharma²⁸ is a biotech and health technology company focused on rare and ultra-rare disease.
We combine regulatory execution, clinical infrastructure and a proprietary data intelligence layer to translate innovation into access across Brazil and internationally.
Our mission
To build the infrastructure — clinical, regulatory, technological — that lets rare disease innovation reach the patients it was designed for.
How we differ
We are not a distributor. We are not a consultancy. We are an operating platform that owns the coordination between therapeutic developer, clinical system, regulator, data infrastructure and patient community — end to end.
Five principles
- 01
Science Before Narrative
Evidence sets the story, not the other way around.
- 02
Local Depth, Global Fluency
Brazilian execution shaped by international scientific standards.
- 03
Data With Governance
Rigor, consent and transparency in every data workflow.
- 04
Partnership, Not Handoff
We remain accountable across the entire pathway.
- 05
Evidence Over Assumption
Real-world data disciplines every access decision.
Brazil is our operating base. Boston is our scientific corridor. The rest of the world is our reference standard.
Leadership
Pharma²⁸ is led by an operating team that combines biotech business development, clinical medicine, regulatory execution and data engineering — coordinated across São Paulo and Boston.
Pharma²⁸ works alongside experienced physicians, physician-scientists, academic leaders and healthcare institutions to support rare disease programs with the clinical credibility and local insight required for responsible international development.
Building rare disease infrastructure, together.
If you are advancing a therapy, investing in the space, running a clinical program or coordinating patient identification — start a conversation with us.